Annual EBITDA:
-$175.87M-$148.93M(-552.77%)Summary
- As of today, CDTX annual EBITDA is -$175.87 million, with the most recent change of -$148.93 million (-552.77%) on December 31, 2024.
- During the last 3 years, CDTX annual EBITDA has fallen by -$133.61 million (-316.21%).
- CDTX annual EBITDA is now -16154.07% below its all-time high of -$1.08 million, reached on December 31, 2013.
Performance
CDTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$27.36M-$2.14M(-8.47%)Summary
- As of today, CDTX quarterly EBITDA is -$27.36 million, with the most recent change of -$2.14 million (-8.47%) on June 30, 2025.
- Over the past year, CDTX quarterly EBITDA has dropped by -$16.31 million (-147.71%).
- CDTX quarterly EBITDA is now -282.87% below its all-time high of $14.96 million, reached on September 30, 2022.
Performance
CDTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$124.03M-$16.31M(-15.14%)Summary
- As of today, CDTX TTM EBITDA is -$124.03 million, with the most recent change of -$16.31 million (-15.14%) on June 30, 2025.
- Over the past year, CDTX TTM EBITDA has dropped by -$91.39 million (-280.03%).
- CDTX TTM EBITDA is now -22088.37% below its all-time high of -$559.00 thousand, reached on March 31, 2014.
Performance
CDTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CDTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -552.8% | -147.7% | -280.0% |
| 3Y3 Years | -316.2% | -108.6% | -89.1% |
| 5Y5 Years | -321.5% | -50.7% | -93.2% |
CDTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -552.8% | at low | -282.9% | +49.5% | -1976.6% | at low |
| 5Y | 5-Year | -552.8% | at low | -282.9% | +49.5% | -1976.6% | at low |
| All-Time | All-Time | >-9999.0% | at low | -282.9% | +49.5% | >-9999.0% | at low |
CDTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$27.36M(-8.5%) | -$124.03M(-15.1%) |
| Mar 2025 | - | -$25.22M(+53.4%) | -$107.72M(-18.4%) |
| Dec 2024 | -$175.87M(-552.8%) | -$54.12M(-212.3%) | -$90.99M(-99.9%) |
| Sep 2024 | - | -$17.33M(-56.9%) | -$45.52M(-39.5%) |
| Jun 2024 | - | -$11.04M(-30.1%) | -$32.64M(-15.3%) |
| Mar 2024 | - | -$8.49M(+2.0%) | -$28.32M(-66.4%) |
| Dec 2023 | -$26.94M(+19.2%) | -$8.66M(-94.8%) | -$17.02M(+32.9%) |
| Sep 2023 | - | -$4.45M(+33.9%) | -$25.38M(-324.9%) |
| Jun 2023 | - | -$6.72M(-339.0%) | -$5.97M(+51.7%) |
| Mar 2023 | - | $2.81M(+116.5%) | -$12.36M(+62.7%) |
| Dec 2022 | -$33.36M(+21.1%) | -$17.02M(-213.8%) | -$33.14M(-0.8%) |
| Sep 2022 | - | $14.96M(+214.1%) | -$32.89M(+49.9%) |
| Jun 2022 | - | -$13.11M(+27.0%) | -$65.59M(-58.3%) |
| Mar 2022 | - | -$17.96M(-7.1%) | -$41.44M(-0.0%) |
| Dec 2021 | -$42.26M(+40.3%) | -$16.77M(+5.5%) | -$41.43M(+8.6%) |
| Sep 2021 | - | -$17.74M(-260.7%) | -$45.35M(-0.6%) |
| Jun 2021 | - | $11.04M(+161.5%) | -$45.07M(+39.3%) |
| Mar 2021 | - | -$17.96M(+13.2%) | -$74.26M(-4.9%) |
| Dec 2020 | -$70.80M(-69.7%) | -$20.68M(-18.4%) | -$70.80M(-10.3%) |
| Sep 2020 | - | -$17.46M(+3.8%) | -$64.20M(-47.1%) |
| Jun 2020 | - | -$18.15M(-25.2%) | -$43.63M(-10.0%) |
| Mar 2020 | - | -$14.50M(-3.0%) | -$39.68M(+4.2%) |
| Dec 2019 | -$41.72M | -$14.08M(-553.9%) | -$41.42M(+5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $3.10M(+121.9%) | -$43.83M(+28.8%) |
| Jun 2019 | - | -$14.20M(+12.6%) | -$61.52M(+1.3%) |
| Mar 2019 | - | -$16.25M(+1.5%) | -$62.34M(+0.7%) |
| Dec 2018 | -$62.76M(-14.0%) | -$16.49M(-13.0%) | -$62.76M(-5.3%) |
| Sep 2018 | - | -$14.59M(+2.9%) | -$59.59M(-4.3%) |
| Jun 2018 | - | -$15.02M(+9.9%) | -$57.11M(+2.4%) |
| Mar 2018 | - | -$16.67M(-25.2%) | -$58.52M(-6.3%) |
| Dec 2017 | -$55.05M(-15.4%) | -$13.32M(-10.0%) | -$55.05M(+1.5%) |
| Sep 2017 | - | -$12.11M(+26.3%) | -$55.90M(+0.1%) |
| Jun 2017 | - | -$16.43M(-24.5%) | -$55.95M(-9.3%) |
| Mar 2017 | - | -$13.20M(+6.8%) | -$51.20M(-7.3%) |
| Dec 2016 | -$47.70M(-49.8%) | -$14.17M(-16.5%) | -$47.70M(-10.2%) |
| Sep 2016 | - | -$12.16M(-4.2%) | -$43.29M(-7.6%) |
| Jun 2016 | - | -$11.67M(-20.3%) | -$40.24M(-15.2%) |
| Mar 2016 | - | -$9.71M(+0.5%) | -$34.92M(-9.6%) |
| Dec 2015 | -$31.85M(-223.8%) | -$9.76M(-7.1%) | -$31.85M(-19.5%) |
| Sep 2015 | - | -$9.11M(-43.5%) | -$26.66M(-28.2%) |
| Jun 2015 | - | -$6.35M(+4.4%) | -$20.80M(-30.6%) |
| Mar 2015 | - | -$6.64M(-45.7%) | -$15.92M(-61.8%) |
| Dec 2014 | -$9.84M(-809.1%) | -$4.56M(-40.3%) | -$9.84M(-86.4%) |
| Sep 2014 | - | -$3.25M(-121.2%) | -$5.28M(-160.3%) |
| Jun 2014 | - | -$1.47M(-162.8%) | -$2.03M(-262.8%) |
| Mar 2014 | - | -$559.00K | -$559.00K |
| Dec 2013 | -$1.08M | - | - |
FAQ
- What is Cidara Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Cidara Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Cidara Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Cidara Therapeutics, Inc.?
- What is Cidara Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Cidara Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of CDTX is -$175.87M
What is the all-time high annual EBITDA for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high annual EBITDA is -$1.08M
What is Cidara Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, CDTX annual EBITDA has changed by -$148.93M (-552.77%)
What is Cidara Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of CDTX is -$27.36M
What is the all-time high quarterly EBITDA for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high quarterly EBITDA is $14.96M
What is Cidara Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, CDTX quarterly EBITDA has changed by -$16.31M (-147.71%)
What is Cidara Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of CDTX is -$124.03M
What is the all-time high TTM EBITDA for Cidara Therapeutics, Inc.?
Cidara Therapeutics, Inc. all-time high TTM EBITDA is -$559.00K
What is Cidara Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, CDTX TTM EBITDA has changed by -$91.39M (-280.03%)